Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,249,353
  • Shares Outstanding, K 54,058
  • Annual Sales, $ 579,780 K
  • Annual Income, $ 53,420 K
  • 60-Month Beta 0.99
  • Price/Sales 3.78
  • Price/Cash Flow 21.17
  • Price/Book 2.61
Trade SUPN with:

Options Overview Details

View History
  • Implied Volatility 41.80% ( -6.29%)
  • Historical Volatility 25.14%
  • IV Percentile 18%
  • IV Rank 19.74%
  • IV High 103.16% on 05/10/22
  • IV Low 26.70% on 03/11/22
  • Put/Call Vol Ratio 0.25
  • Today's Volume 15
  • Volume Avg (30-Day) 82
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 1,777
  • Open Int (30-Day) 1,416

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.73
  • Number of Estimates 3
  • High Estimate 0.87
  • Low Estimate 0.65
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +1,725.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.10 +6.96%
on 01/11/23
42.09 -3.18%
on 02/02/23
+1.37 (+3.48%)
since 01/06/23
3-Month
31.92 +27.66%
on 11/09/22
42.09 -3.18%
on 02/02/23
+6.75 (+19.85%)
since 11/04/22
52-Week
24.95 +63.33%
on 05/11/22
42.09 -3.18%
on 02/02/23
+9.82 (+31.75%)
since 02/04/22

Most Recent Stories

More News
Supernus Pharmaceuticals (SUPN) Misses Q3 Earnings Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -90.63% and 2.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 40.75 (-2.07%)
FIXX : 1.6000 (-5.33%)
Supernus: Q3 Earnings Snapshot

Supernus: Q3 Earnings Snapshot

SUPN : 40.75 (-2.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (""Supernus" or the "Company") (NASDAQ: SUPN)....

SUPN : 40.75 (-2.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (""Supernus" or the "Company") (NASDAQ: SUPN)....

SUPN : 40.75 (-2.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN)....

SUPN : 40.75 (-2.07%)
Should You Follow the Insider Buying in Summit Therapeutics

Shares of the biopharmaceutical company Summit Therapeutics (SMMT) gained over the past few days, driven by significant insider buying. However, as the stock is down more than 55% this year, would it be...

JNJ : 163.36 (-0.76%)
LLY : 337.66 (-0.42%)
NVS : 85.47 (-0.44%)
SMMT : 2.98 (-5.10%)
SUPN : 40.75 (-2.07%)
Best Momentum Stocks to Buy for August 8th

CLH, NETI and SUPN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 8, 2022.

CLH : 131.16 (-0.57%)
SUPN : 40.75 (-2.07%)
NETI : 9.79 (-0.10%)
Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -53.33% and 2.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 40.75 (-2.07%)
BHC : 7.69 (-2.16%)
Supernus Announces Second Quarter 2022 Financial Results

Second quarter 2022 total revenues of $170.1 million, a 20% increase compared to second quarter 2021Second quarter 2022 GAAP operating earnings of $11.3...

SUPN : 40.75 (-2.07%)
Supernus Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022

ROCKVILLE, Md., July 25, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

SUPN : 40.75 (-2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 42.37
2nd Resistance Point 41.98
1st Resistance Point 41.37
Last Price 40.75
1st Support Level 40.37
2nd Support Level 39.98
3rd Support Level 39.37

See More

52-Week High 42.09
Last Price 40.75
Fibonacci 61.8% 35.54
Fibonacci 50% 33.52
Fibonacci 38.2% 31.50
52-Week Low 24.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar